Abstract: The purpose of the present invention is to provide a compound having a tetrahydroquinoline skeleton, said compound having ferroptosis inhibitory action and exhibiting a treatment effect or a prevention effect for a disease, disorder, or syndrome related to ferroptosis inhibition such as multiple sclerosis. The present invention provides a tetrahydroquinoline derivative represented by the formula, or a pharmacologically acceptable salt thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202337049199-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [21-07-2023(online)].pdf | 2023-07-21 |
| 2 | 202337049199-STATEMENT OF UNDERTAKING (FORM 3) [21-07-2023(online)].pdf | 2023-07-21 |
| 3 | 202337049199-PROOF OF RIGHT [21-07-2023(online)].pdf | 2023-07-21 |
| 4 | 202337049199-POWER OF AUTHORITY [21-07-2023(online)].pdf | 2023-07-21 |
| 5 | 202337049199-FORM 1 [21-07-2023(online)].pdf | 2023-07-21 |
| 6 | 202337049199-DRAWINGS [21-07-2023(online)].pdf | 2023-07-21 |
| 7 | 202337049199-DECLARATION OF INVENTORSHIP (FORM 5) [21-07-2023(online)].pdf | 2023-07-21 |
| 8 | 202337049199-COMPLETE SPECIFICATION [21-07-2023(online)].pdf | 2023-07-21 |
| 9 | 202337049199-certified copy of translation [21-07-2023(online)].pdf | 2023-07-21 |
| 10 | 202337049199-FORM 18 [19-09-2024(online)].pdf | 2024-09-19 |